NSN 6505-01-693-4566 · NIIN 016934566 · FSC 6505
NO DASHES 6505016934566
In Stock
QUETIAPINE FUMARATE TABLETS
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | QUETIAPINE FUMARATE TABLETS, 150MG, 60S |
| FEAT | SPECIAL FEATURES | QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS ARE INDICATED FOR THE TREATMENT OF SCHIZOPHRENIA; INDICATED FOR THE ACUTE TREATMENT OF MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER, BOTH AS MONOTHERAPY AND AS AN ADJUNCT TO LITHIUM OR DIVALPROEX; 150 MG QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS ARE WHITE, FILM-COATED, CAPSULE-SHAPED, BICONVEX, DEBOSSED TABLET WITH "NT 150" ON ONE SIDE AND PLAIN ON THE OTHER SIDE; STORE QUETIAPINE FUMARATE EXTENDED-RELEASE TABLETS AT 25 C (77 F); EXCURSIONS PERMITTED TO 15-30 C (59-86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); SWALLOW WHOLE - DO NOT SPLIT, CRUSH OR CHEW; BOTTLE OF 60 TABLETS. |
Cross-references
6 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC51407-0074-60 | 1HT23 |
| NDC00310-0281-60 | 36WK2 |
| SEROGUEL XR | 36WK2 |
| 6505NCM216859 | 64616 |
| NDC52818-0161-60 | 7WGD5 |
| 1589159 | 89875 |